Academics and industry leaders in robotics toured Carnegie Mellon’s facilities as part of the Conference on Intelligent Robots and Systems (IROS).

Carnegie Mellon University Miami, announced today, is set to embrace this more dynamic model of knowledge building and problem solving. Rather than beginning with conventional academic structures and ...

A landmark $500 million gift will transform Carnegie Mellon University’s top-ranked School of Computer Science into a global powerhouse shaping students, research and technologies to address emerging ...

Dear Members of the Carnegie Mellon Community: I am writing this morning to share one of the most significant developments in Carnegie Mellon University’s history — a moment that will strengthen our ...

Long-term medical treatment for chronic lung disease has stumped doctors and scientists for years. Now, researchers from Carnegie Mellon University have created new artificial lung technology that ...

Dear Members of the CMU Community: We are writing to share details of a situation that goes to the heart of faculty responsibility, academic standards and the trust that is foundational to our ...

Dr. Uju Anya is currently on voluntary professional leave from the university and is not teaching courses on our campus this academic year. We are deeply concerned by recent hostile and threatening ...

As artificial intelligence moves deeper into workplaces, healthcare and everyday decision-making, Carnegie Mellon University researchers are exploring how AI can help people make better decisions ...

Carnegie Mellon University is weaving AI into coursework across campus to ignite student curiosity, creativity and critical rigor. Whether exploring the ethics of algorithmic decision-making or ...

For decades, neuroscience and artificial intelligence have pursued a similar question from different directions, examining how intelligence emerges from a system that can perceive the world, learn ...

Developing treatments for rare diseases presents many challenges: small patient populations, fragmented data and long, complex paths to new therapies. But rare doesn’t mean few. More than 400 million ...